Alkem Laboratories Schedules Virtual Investor Meeting with Millennium Capital Management
Alkem Laboratories Limited has scheduled a virtual analyst meeting with Millennium Capital Management for March 26, 2026, and has duly informed stock exchanges BSE and NSE as required under SEBI LODR regulations. The meeting schedule remains flexible and subject to change based on operational requirements from either party.
*this image is generated using AI for illustrative purposes only.
Alkem Laboratories Limited has announced a scheduled virtual meeting with institutional investor Millennium Capital Management, set to take place on March 26, 2026. The pharmaceutical company disclosed this information to stock exchanges as part of its regulatory obligations under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
The company has provided specific details about the upcoming investor engagement:
| Parameter: | Details |
|---|---|
| Date: | March 26, 2026 |
| Investor: | Millennium Capital Management |
| Meeting Type: | Virtual |
| Disclosure Date: | March 20, 2026 |
Regulatory Compliance
Alkem Laboratories communicated this information to both major Indian stock exchanges - BSE Limited and the National Stock Exchange of India Limited. The company emphasized that this disclosure aligns with the relevant provisions of SEBI's listing regulations, which mandate transparency in investor communications.
Schedule Flexibility
The pharmaceutical company has indicated that the meeting schedule remains subject to potential changes. According to the official communication, any modifications could occur due to exigencies on the part of either the investor or the company. This standard disclaimer provides flexibility for both parties to adjust timing if operational requirements necessitate changes.
Corporate Communication
The disclosure was signed by Manish Narang, who serves as President – Legal, Company Secretary & Compliance Officer at Alkem Laboratories. The document was digitally signed and dated March 20, 2026, demonstrating the company's commitment to timely regulatory reporting and maintaining transparency with stakeholders regarding investor engagement activities.
Historical Stock Returns for Alkem Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.33% | -3.43% | -2.22% | -5.12% | +8.36% | +100.30% |
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
